ArticlePharmacology research & perspectives2026

RETRACTION: Ivermectin Synergizes Sorafenib in Hepatocellular Carcinoma via Targeting Multiple Oncogenic Pathways.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.